BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10637511)

  • 41. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
    Chansky HA; Hu M; Hickstein DD; Yang L
    Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells.
    Filion C; Labelle Y
    Exp Cell Res; 2004 Jul; 297(2):585-92. PubMed ID: 15212958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
    May WA; Denny CT
    Curr Top Microbiol Immunol; 1997; 220():143-50. PubMed ID: 9103680
    [No Abstract]   [Full Text] [Related]  

  • 44. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.
    Maire G; Brown CW; Bayani J; Pereira C; Gravel DH; Bell JC; Zielenska M; Squire JA
    Cancer Genet Cytogenet; 2008 Mar; 181(2):81-92. PubMed ID: 18295659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.
    Dohjima T; Ohno T; Banno Y; Nozawa Y; Wen-yi Y; Shimizu K
    Br J Cancer; 2000 Jan; 82(1):16-9. PubMed ID: 10638960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
    Lee J; Rhee BK; Bae GY; Han YM; Kim J
    Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fli-1 (Friend leukemia integration 1). Oncogene].
    Bull Cancer; 1998 Oct; 85(10):830. PubMed ID: 9867365
    [No Abstract]   [Full Text] [Related]  

  • 49. [The EWS gene rearrangement in Ewing tumors: key to the disease].
    Kovar H; Zoubek A; Pfleiderer C; Jug G; Auinger A; Aryee D; Ambros PF; Salzer-Kuntschik M; Amann G; Windhager R
    Klin Padiatr; 1994; 206(4):196-200. PubMed ID: 7967416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. E1A and the Ewing tumor translocation.
    Kovar H
    Nat Med; 1999 Dec; 5(12):1331. PubMed ID: 10581050
    [No Abstract]   [Full Text] [Related]  

  • 51. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct.
    Kim J; Lee K; Pelletier J
    Oncogene; 1998 Feb; 16(8):1021-30. PubMed ID: 9519876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein.
    Takahama K; Kino K; Arai S; Kurokawa R; Oyoshi T
    FEBS J; 2011 Apr; 278(6):988-98. PubMed ID: 21244633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SRE elements are binding sites for the fusion protein EWS-FLI-1.
    Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
    Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissociation of transcriptional activation and oncogenic transformation by v-Myb.
    Chen RH; Fields S; Lipsick JS
    Oncogene; 1995 Nov; 11(9):1771-9. PubMed ID: 7478605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
    Zucman J; Melot T; Desmaze C; Ghysdael J; Plougastel B; Peter M; Zucker JM; Triche TJ; Sheer D; Turc-Carel C
    EMBO J; 1993 Dec; 12(12):4481-7. PubMed ID: 8223458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.
    Chan D; Wilson TJ; Xu D; Cowdery HE; Sanij E; Hertzog PJ; Kola I
    Br J Cancer; 2003 Jan; 88(1):137-45. PubMed ID: 12556973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
    Mao X; Miesfeldt S; Yang H; Leiden JM; Thompson CB
    J Biol Chem; 1994 Jul; 269(27):18216-22. PubMed ID: 7517940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.
    Bertolotti A; Melot T; Acker J; Vigneron M; Delattre O; Tora L
    Mol Cell Biol; 1998 Mar; 18(3):1489-97. PubMed ID: 9488465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
    Zinszner H; Albalat R; Ron D
    Genes Dev; 1994 Nov; 8(21):2513-26. PubMed ID: 7958914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).
    Panagopoulos I; Mencinger M; Dietrich CU; Bjerkehagen B; Saeter G; Mertens F; Mandahl N; Heim S
    Oncogene; 1999 Dec; 18(52):7594-8. PubMed ID: 10602519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.